결과 페이지 2 - 국가: 독일 부문: 보건의료 업종: 생명공학 주식 시장 - 시세 및 가격
가격, 시가 총액, PE 및 EPS가 포함된 모든 주식 목록
| 이름 이름 | 가격 가격 |
24h% 7d chart 24h% & 7d |
시가 총액 시가 총액 | 거래량 거래량 | 24h 최저가 | 24h 최고가 | 시가 총액 | 주가수익비율 | 주당순이익 | 예측 |
|---|
| 이름 이름 | 가격 가격 |
24h% 7d chart 24h% & 7d |
시가 총액 시가 총액 | 거래량 거래량 | 24h 최저가 | 24h 최고가 | 시가 총액 | 주가수익비율 | 주당순이익 | 예측 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} |
|
|
Genscript Biotech Corporation
G51.F
DE
|
€1.19 1.37 USD |
-1.65
|
€2.60B 3B USD | €840.00 969.64 USD | €1.19 1.37 USD | €1.19 1.37 USD | €2.60B 3B USD | 0 | -€0.21 -0.2 USD | ||
Ultragenyx Pharmaceutical Inc.
UP0.F
DE
|
€25.09 28.96 USD |
+5.95
|
€2.47B 2.85B USD | €229.00 264.34 USD | €25.09 28.96 USD | €25.09 28.96 USD | €2.47B 2.85B USD | 0 | -€5.32 -6.1 USD | ||
BioArctic AB (publ)
B9A.F
DE
|
€27.78 32.07 USD |
-0.22
|
€2.46B 2.85B USD | €33.00 38.09 USD | €27.78 32.07 USD | €27.78 32.07 USD | €2.46B 2.85B USD | 126.27 | €0.22 0.25 USD | ||
uniQure N.V.
UQ1.F
DE
|
€38.75 44.73 USD |
-4.91
|
€2.44B 2.82B USD | €25.00 28.86 USD | €38.75 44.73 USD | €38.75 44.73 USD | €2.44B 2.82B USD | 0 | -€3.04 -3.5 USD | ||
Celldex Therapeutics, Inc.
TCE2.F
DE
|
€28.81 33.26 USD |
+3.11
|
€2.26B 2.61B USD | €200.00 230.87 USD | €28.81 33.26 USD | €28.81 33.26 USD | €2.26B 2.61B USD | 0 | -€3.72 -4.2 USD | ||
Pharvaris N.V.
9EN.F
DE
|
€28.85 33.3 USD |
0
|
€2.02B 2.33B USD | €165.00 190.47 USD | €28.05 32.38 USD | €28.95 33.42 USD | €2.02B 2.33B USD | 0 | -€2.72 -3.1 USD | ||
Kodiak Sciences Inc.
K27.F
DE
|
€31.76 36.66 USD |
-0.38
|
€1.99B 2.29B USD | €50.00 57.72 USD | €31.76 36.66 USD | €31.76 36.66 USD | €1.99B 2.29B USD | 0 | -€3.64 -4.2 USD | ||
Aurinia Pharmaceuticals Inc.
IKAP.F
DE
|
€15.18 17.52 USD |
-0.46
|
€1.95B 2.25B USD | €530.00 611.8 USD | €15.18 17.52 USD | €15.18 17.52 USD | €1.95B 2.25B USD | 8.07 | €1.88 2.17 USD | ||
Intellia Therapeutics, Inc.
38I.F
DE
|
€13.26 15.31 USD |
+2.16
|
€1.85B 2.14B USD | €120.00 138.52 USD | €13.26 15.31 USD | €13.26 15.31 USD | €1.85B 2.14B USD | 0 | -€3.07 -3.5 USD | ||
Ocular Therapeutix, Inc.
0OT.F
DE
|
€8.40 9.7 USD |
+5
|
€1.84B 2.12B USD | €100.00 115.43 USD | €8.40 9.7 USD | €8.40 9.7 USD | €1.84B 2.12B USD | 0 | -€1.26 -1.4 USD | ||
Agios Pharmaceuticals, Inc.
8AP.F
DE
|
€30.00 34.63 USD |
+2.04
|
€1.78B 2.06B USD | €180.00 207.78 USD | €30.00 34.63 USD | €30.00 34.63 USD | €1.78B 2.06B USD | 0 | -€6.33 -7.3 USD | ||
Vericel Corporation
ATQP.F
DE
|
€34.60 39.94 USD |
-0.57
|
€1.77B 2.04B USD | €100.00 115.43 USD | €34.60 39.94 USD | €34.60 39.94 USD | €1.77B 2.04B USD | 91.05 | €0.38 0.44 USD | ||
BAVARIAN NORDIC N
BV3.DE
DE
|
€23.06 26.62 USD |
0
|
€1.76B 2.03B USD | €721.00 832.28 USD | €22.96 26.5 USD | €23.52 27.15 USD | €1.76B 2.03B USD | 11.41 | €2.02 2.33 USD | ||
Bavarian Nordic A/S
BV3.F
DE
|
€22.60 26.09 USD |
-0.62
|
€1.72B 1.99B USD | €50.00 57.72 USD | €22.60 26.09 USD | €22.60 26.09 USD | €1.72B 1.99B USD | 11.18 | €2.02 2.33 USD | ||
Mesoblast Limited
LWB.F
DE
|
€1.33 1.53 USD |
+2.07
|
€1.72B 1.98B USD | €162.00 187 USD | €1.33 1.53 USD | €1.33 1.53 USD | €1.72B 1.98B USD | 0 | -€0.06 -0.06 USD | ||
Zai Lab Limited
1ZL.F
DE
|
€15.20 17.55 USD |
-5
|
€1.71B 1.97B USD | €500.00 577.17 USD | €15.20 17.55 USD | €15.20 17.55 USD | €1.71B 1.97B USD | 0 | -€1.48 -1.7 USD | ||
Viridian Therapeutics, Inc.
1S1.F
DE
|
€15.20 17.55 USD |
+5.56
|
€1.68B 1.94B USD | €4.00 4.62 USD | €15.20 17.55 USD | €15.20 17.55 USD | €1.68B 1.94B USD | 0 | -€2.92 -3.3 USD | ||
Maravai LifeSciences Holdings, Inc.
MAR.F
DE
|
€4.52 5.22 USD |
-0.44
|
€1.67B 1.92B USD | €1.25K 1.44K USD | €4.52 5.22 USD | €4.52 5.22 USD | €1.67B 1.92B USD | 0 | -€0.62 -0.7 USD | ||
Genus plc
GBE.F
DE
|
€24.80 28.63 USD |
-0.8
|
€1.65B 1.9B USD | €1.00 1.15 USD | €24.80 28.63 USD | €24.80 28.63 USD | €1.65B 1.9B USD | 30.24 | €0.82 0.95 USD | ||
Stoke Therapeutics, Inc.
0GT.F
DE
|
€26.28 30.34 USD |
-1.28
|
€1.64B 1.89B USD | €606.00 699.53 USD | €26.28 30.34 USD | €26.28 30.34 USD | €1.64B 1.89B USD | 0 | -€2.49 -2.8 USD | ||
Lakefront Biotherapeutics NV
GXEA.F
DE
|
€24.80 28.63 USD |
+0.81
|
€1.63B 1.89B USD | €86.00 99.27 USD | €24.80 28.63 USD | €24.80 28.63 USD | €1.63B 1.89B USD | 3.34 | €7.41 8.55 USD | ||
Lakefront Biotherapeutics NV
GXE.F
DE
|
€24.64 28.44 USD |
-0.32
|
€1.62B 1.87B USD | €91.00 105.04 USD | €24.64 28.44 USD | €24.64 28.44 USD | €1.62B 1.87B USD | 3.32 | €7.41 8.55 USD | ||
Lakefront Biotherapeutics NV
GXE.DE
DE
|
€24.46 28.24 USD |
0
|
€1.61B 1.86B USD | €6.00 6.93 USD | €24.46 28.24 USD | €24.46 28.24 USD | €1.61B 1.86B USD | 3.30 | €7.41 8.55 USD | ||
Sarepta Therapeutics, Inc.
AB3A.F
DE
|
€15.12 17.45 USD |
+0.4
|
€1.60B 1.84B USD | €150.00 173.15 USD | €15.12 17.45 USD | €15.12 17.45 USD | €1.60B 1.84B USD | 48.77 | €0.31 0.36 USD | ||
Biotest AG
BIO.HM
DE
|
€40.00 46.17 USD |
+2.04
|
€1.58B 1.83B USD | €0.00 0 USD | €0.00 0 USD | €0.00 0 USD | €1.58B 1.83B USD | 0 | -€0.63 -0.7 USD | ||
Nanobiotix S.A.
5NRA.F
DE
|
€30.80 35.55 USD |
+5.48
|
€1.56B 1.81B USD | €1.00 1.15 USD | €30.80 35.55 USD | €30.80 35.55 USD | €1.56B 1.81B USD | 0 | -€0.50 -0.5 USD | ||
Iovance Biotherapeutics, Inc.
2LB.F
DE
|
€3.50 4.03 USD |
+0.14
|
€1.56B 1.8B USD | €1.00K 1.15K USD | €3.50 4.03 USD | €3.50 4.03 USD | €1.56B 1.8B USD | 0 | -€0.80 -0.9 USD | ||
Precigen, Inc.
I5X.F
DE
|
€4.16 4.8 USD |
0
|
€1.48B 1.71B USD | €500.00 577.17 USD | €4.16 4.8 USD | €4.16 4.8 USD | €1.48B 1.71B USD | 0 | -€1.06 -1.2 USD | ||
Palvella Therapeutics Inc. R
PI6.F
DE
|
€103.00 118.9 USD |
+5.1
|
€1.48B 1.71B USD | €1.00 1.15 USD | €103.00 118.9 USD | €103.00 118.9 USD | €1.48B 1.71B USD | 0 | -€3.63 -4.1 USD | ||
Nanobiotix S.A.
5NR.F
DE
|
€29.04 33.52 USD |
+1.97
|
€1.47B 1.7B USD | €345.00 398.25 USD | €29.04 33.52 USD | €29.04 33.52 USD | €1.47B 1.7B USD | 0 | -€0.50 -0.5 USD | ||
Syndax Pharmaceuticals, Inc.
1T3.F
DE
|
€16.57 19.13 USD |
-0.63
|
€1.47B 1.69B USD | €405.00 467.51 USD | €16.57 19.13 USD | €16.57 19.13 USD | €1.47B 1.69B USD | 0 | -€2.43 -2.8 USD | ||
AbCellera Biologics Inc.
8QQ.F
DE
|
€4.78 5.52 USD |
+0.74
|
€1.46B 1.68B USD | €3.04K 3.5K USD | €4.78 5.52 USD | €4.78 5.52 USD | €1.46B 1.68B USD | 0 | -€0.42 -0.4 USD | ||
Capricor Therapeutics, Inc.
4LN2.F
DE
|
€25.10 28.97 USD |
0
|
€1.45B 1.68B USD | €200.00 230.87 USD | €24.23 27.97 USD | €25.10 28.97 USD | €1.45B 1.68B USD | 0 | -€2.03 -2.3 USD | ||
UroGen Pharma Ltd.
UR8.F
DE
|
€29.83 34.43 USD |
+4.37
|
€1.45B 1.68B USD | €62.00 71.57 USD | €29.83 34.43 USD | €29.83 34.43 USD | €1.45B 1.68B USD | 0 | -€2.39 -2.7 USD | ||
SELLAS Life Sciences Group, Inc.
RXK3.F
DE
|
€7.36 8.5 USD |
+4.55
|
€1.45B 1.67B USD | €6.80K 7.85K USD | €7.36 8.5 USD | €7.36 8.5 USD | €1.45B 1.67B USD | 0 | -€0.20 -0.2 USD | ||
Innoviva, Inc.
HVE.F
DE
|
€19.60 22.62 USD |
-1.51
|
€1.45B 1.67B USD | €250.00 288.58 USD | €19.60 22.62 USD | €19.60 22.62 USD | €1.45B 1.67B USD | 3.58 | €5.46 6.3 USD | ||
Ardelyx, Inc.
41X.F
DE
|
€5.51 6.36 USD |
-0.72
|
€1.36B 1.57B USD | €1.81K 2.08K USD | €5.51 6.36 USD | €5.51 6.36 USD | €1.36B 1.57B USD | 0 | -€0.21 -0.2 USD | ||
Ascentage Pharma Group International
36X.F
DE
|
€3.46 3.99 USD |
-0.57
|
€1.29B 1.49B USD | €21.00 24.24 USD | €3.46 3.99 USD | €3.46 3.99 USD | €1.29B 1.49B USD | 0 | -€0.45 -0.5 USD | ||
GH Research PLC
1KA.F
DE
|
€18.80 21.7 USD |
-0.53
|
€1.29B 1.49B USD | €400.00 461.73 USD | €18.80 21.7 USD | €18.80 21.7 USD | €1.29B 1.49B USD | 0 | -€0.79 -0.9 USD | ||
AtaiBeckley Inc.
9VC.F
DE
|
€3.55 4.09 USD |
0
|
€1.29B 1.49B USD | €0.00 0 USD | €0.00 0 USD | €0.00 0 USD | €1.29B 1.49B USD | 0 | €0.00 0 USD | ||
Immunocore Holdings plc
6YG.F
DE
|
€25.20 29.09 USD |
-0.79
|
€1.28B 1.48B USD | €4.00 4.62 USD | €25.20 29.09 USD | €25.20 29.09 USD | €1.28B 1.48B USD | 0 | -€0.49 -0.5 USD | ||
Novavax, Inc.
NVV1.F
DE
|
€7.79 8.99 USD |
-3.59
|
€1.28B 1.48B USD | €55.00 63.49 USD | €7.79 8.99 USD | €7.79 8.99 USD | €1.28B 1.48B USD | 0 | -€0.49 -0.5 USD | ||
AtaiBeckley Inc.
9VC.DE
DE
|
€3.43 3.95 USD |
0
|
€1.27B 1.47B USD | €0.00 0 USD | €0.00 0 USD | €0.00 0 USD | €1.27B 1.47B USD | 0 | €0.00 0 USD | ||
Oxford Nanopore Technologies plc
4R0.F
DE
|
€1.26 1.46 USD |
-2.62
|
€1.23B 1.42B USD | €30.00 34.63 USD | €1.26 1.46 USD | €1.26 1.46 USD | €1.23B 1.42B USD | 0 | -€0.17 -0.1 USD | ||
KalVista Pharmaceuticals, Inc.
4XC1.F
DE
|
€22.73 26.24 USD |
0
|
€1.21B 1.4B USD | €300.00 346.3 USD | €22.73 26.24 USD | €22.73 26.24 USD | €1.21B 1.4B USD | 0 | -€3.40 -3.9 USD | ||
Pharma Mar, S.A.
PMRA.F
DE
|
€68.05 78.55 USD |
-1.8
|
€1.19B 1.37B USD | €45.00 51.95 USD | €68.05 78.55 USD | €68.05 78.55 USD | €1.19B 1.37B USD | 14.72 | €4.62 5.33 USD | ||
Immatics N.V.
4A3.F
DE
|
€8.49 9.8 USD |
-4.61
|
€1.16B 1.34B USD | €41.00 47.33 USD | €8.49 9.8 USD | €8.49 9.8 USD | €1.16B 1.34B USD | 0 | -€1.71 -1.9 USD | ||
Ascletis Pharma Inc.
2VJ.F
DE
|
€1.09 1.26 USD |
+3.81
|
€1.15B 1.32B USD | €1.80K 2.08K USD | €1.09 1.26 USD | €1.09 1.26 USD | €1.15B 1.32B USD | 0 | -€0.05 -0.05 USD | ||
MannKind Corporation
NNFN.F
DE
|
€3.24 3.74 USD |
-4.51
|
€1.00B 1.16B USD | €10.00 11.54 USD | €3.24 3.74 USD | €3.24 3.74 USD | €1.00B 1.16B USD | 0 | -€0.06 -0.06 USD | ||
Savara Inc.
YB4P.F
DE
|
€4.85 5.6 USD |
-2.53
|
€993.49M 1.15B USD | €60.00 69.26 USD | €4.85 5.6 USD | €4.85 5.6 USD | €993.49M 1.15B USD | 0 | -€0.49 -0.5 USD | ||
Wave Life Sciences Ltd.
1U5.F
DE
|
€5.10 5.89 USD |
+0.99
|
€981.25M 1.13B USD | €50.00 57.72 USD | €5.10 5.89 USD | €5.10 5.89 USD | €981.25M 1.13B USD | 0 | -€0.92 -1.06 USD | ||
HBM Holdings Limited
6XY.F
DE
|
€1.14 1.32 USD |
0
|
€952.20M 1.1B USD | €2.88K 3.32K USD | €1.13 1.3 USD | €1.14 1.32 USD | €952.20M 1.1B USD | 11.40 | €0.10 0.12 USD | ||
EyePoint, Inc.
PV3B.F
DE
|
€11.20 12.93 USD |
-1.75
|
€939.02M 1.08B USD | €70.00 80.8 USD | €11.20 12.93 USD | €11.20 12.93 USD | €939.02M 1.08B USD | 0 | -€3.06 -3.5 USD | ||
Everest Medicines Limited
6HN.F
DE
|
€2.66 3.07 USD |
-2.21
|
€934.56M 1.08B USD | €101.00 116.59 USD | €2.66 3.07 USD | €2.66 3.07 USD | €934.56M 1.08B USD | 0 | -€0.11 -0.1 USD | ||
Xencor, Inc.
XE9.F
DE
|
€12.00 13.85 USD |
+13.21
|
€889.70M 1.03B USD | €300.00 346.3 USD | €12.00 13.85 USD | €12.00 13.85 USD | €889.70M 1.03B USD | 0 | -€2.00 -2.3 USD | ||
Corvus Pharmaceuticals, Inc.
C17.F
DE
|
€10.56 12.19 USD |
-3.78
|
€887.99M 1.03B USD | €900.00 1.04K USD | €10.56 12.19 USD | €10.56 12.19 USD | €887.99M 1.03B USD | 0 | -€0.48 -0.5 USD | ||
CureVac N.V.
5CV.F
DE
|
€3.91 4.51 USD |
0
|
€885.32M 1.02B USD | €0.00 0 USD | €0.00 0 USD | €0.00 0 USD | €885.32M 1.02B USD | 0 | €0.00 0 USD | ||
MedinCell S.A.
MEB.F
DE
|
€24.24 27.98 USD |
0
|
€870.38M 1B USD | €285.00 328.99 USD | €23.32 26.92 USD | €24.24 27.98 USD | €870.38M 1B USD | 0 | -€0.87 -1.004 USD | ||
Lexicon Pharmaceuticals, Inc.
LX31.MU
DE
|
€3.53 4.07 USD |
0
|
€864.59M 998.02M USD | €250.00 288.58 USD | €3.53 4.07 USD | €3.53 4.08 USD | €864.59M 998.02M USD | 0 | -€0.55 -0.6 USD | ||
CStone Pharmaceuticals
PH4.F
DE
|
€0.51 0.58 USD |
0
|
€805.66M 930.01M USD | €2.00K 2.31K USD | €0.51 0.58 USD | €0.51 0.59 USD | €805.66M 930.01M USD | 0 | -€0.04 -0.04 USD | ||
Oxford Biomedica plc
OXOA.F
DE
|
€6.65 7.68 USD |
-2.21
|
€804.89M 929.11M USD | €152.00 175.46 USD | €6.65 7.68 USD | €6.65 7.68 USD | €804.89M 929.11M USD | 0 | -€0.31 -0.3 USD | ||
Pharming Group N.V.
PHGN.F
DE
|
€1.12 1.3 USD |
+0.45
|
€804.79M 929M USD | €2.09K 2.41K USD | €1.12 1.3 USD | €1.12 1.3 USD | €804.79M 929M USD | 56.17 | €0.02 0.02 USD | ||
ORIC Pharmaceuticals, Inc.
4TZ.F
DE
|
€7.68 8.87 USD |
+5.69
|
€795.43M 918.19M USD | €700.00 808.03 USD | €7.68 8.87 USD | €7.68 8.87 USD | €795.43M 918.19M USD | 0 | -€1.21 -1.3 USD | ||
DBV Technologies S.A.
DBV.F
DE
|
€2.68 3.1 USD |
-3.11
|
€793.69M 916.19M USD | €780.00 900.38 USD | €2.68 3.1 USD | €2.68 3.1 USD | €793.69M 916.19M USD | 0 | -€0.79 -0.9 USD | ||
Pharming Group N.V.
PHG.F
DE
|
€10.60 12.24 USD |
-2.75
|
€792.25M 914.52M USD | €181.00 208.93 USD | €10.60 12.24 USD | €10.60 12.24 USD | €792.25M 914.52M USD | 62.35 | €0.17 0.2 USD | ||
Replimune Group, Inc.
7R8.F
DE
|
€9.52 10.99 USD |
+9.05
|
€786.09M 907.41M USD | €500.00 577.17 USD | €9.52 10.99 USD | €9.52 10.99 USD | €786.09M 907.41M USD | 0 | -€3.00 -3.4 USD | ||
Arbutus Biopharma Corporation
I9DN.F
DE
|
€3.90 4.5 USD |
-0.26
|
€770.40M 889.3M USD | €3.00K 3.46K USD | €3.90 4.5 USD | €3.90 4.5 USD | €770.40M 889.3M USD | 5.41 | €0.72 0.83 USD | ||
Alphamab Oncology
3NK.F
DE
|
€0.77 0.89 USD |
+3.36
|
€745.87M 860.98M USD | €2.60K 3K USD | €0.77 0.89 USD | €0.77 0.89 USD | €745.87M 860.98M USD | 0 | -€0.02 -0.02 USD | ||
Theravance Biopharma, Inc.
0TB.F
DE
|
€14.40 16.62 USD |
0
|
€742.36M 856.94M USD | €460.00 530.99 USD | €14.40 16.62 USD | €14.40 16.62 USD | €742.36M 856.94M USD | 7.38 | €1.95 2.25 USD | ||
GNI Group Ltd.
3G6.F
DE
|
€13.30 15.35 USD |
+2.31
|
€741.53M 855.97M USD | €1.00 1.15 USD | €13.30 15.35 USD | €13.30 15.35 USD | €741.53M 855.97M USD | 0 | -€0.44 -0.5 USD | ||
Geron Corporation
GON.F
DE
|
€1.15 1.33 USD |
+5.83
|
€739.99M 854.2M USD | €2.00K 2.31K USD | €1.15 1.33 USD | €1.15 1.33 USD | €739.99M 854.2M USD | 0 | -€0.10 -0.1 USD | ||
Takara Bio Inc.
TF2.F
DE
|
€5.95 6.87 USD |
0
|
€716.47M 827.05M USD | €291.00 335.91 USD | €5.95 6.87 USD | €5.95 6.87 USD | €716.47M 827.05M USD | 0 | -€0.43 -0.4 USD | ||
Abbisko Cayman Limited
8ZD.F
DE
|
€0.98 1.13 USD |
-0.51
|
€701.87M 810.19M USD | €14.00 16.16 USD | €0.98 1.13 USD | €0.98 1.13 USD | €701.87M 810.19M USD | 98.00 | €0.01 0.01 USD | ||
Inventiva S.A.
6IV.F
DE
|
€2.90 3.34 USD |
-2.2
|
€683.86M 789.4M USD | €300.00 346.3 USD | €2.90 3.34 USD | €2.90 3.34 USD | €683.86M 789.4M USD | 0 | -€1.90 -2.1 USD | ||
Avalo Therapeutics Inc. R
C6K0.F
DE
|
€12.90 14.89 USD |
0
|
€678.10M 782.75M USD | €12.00 13.85 USD | €12.90 14.89 USD | €12.90 14.89 USD | €678.10M 782.75M USD | 0 | -€4.86 -5.6 USD | ||
Inventiva S.A.
6IVA.F
DE
|
€2.86 3.3 USD |
-2.72
|
€675.59M 779.86M USD | €2.01K 2.31K USD | €2.86 3.3 USD | €2.86 3.3 USD | €675.59M 779.86M USD | 0 | -€1.90 -2.1 USD | ||
Zevra Therapeutics, Inc.
1GDA.F
DE
|
€10.90 12.58 USD |
-1.8
|
€644.35M 743.8M USD | €150.00 173.15 USD | €10.90 12.58 USD | €10.90 12.58 USD | €644.35M 743.8M USD | 6.22 | €1.75 2.02 USD | ||
CK Life Sciences Int'l., (Holdings) Inc.
LSI.F
DE
|
€0.07 0.08 USD |
-1.47
|
€643.94M 743.32M USD | €1.62K 1.87K USD | €0.07 0.08 USD | €0.07 0.08 USD | €643.94M 743.32M USD | 0 | €0.00 0 USD | ||
Omeros Corporation
3O8.F
DE
|
€8.80 10.16 USD |
+0.23
|
€636.90M 735.2M USD | €100.00 115.43 USD | €8.80 10.16 USD | €8.80 10.16 USD | €636.90M 735.2M USD | 8.88 | €0.99 1.14 USD | ||
XOMA Royalty Corporation
X0M1.MU
DE
|
€36.00 41.56 USD |
-1.1
|
€636.43M 734.66M USD | €0.00 0 USD | €36.00 41.56 USD | €36.00 41.56 USD | €636.43M 734.66M USD | 26.27 | €1.37 1.58 USD | ||
XOMA Royalty Corporation
X0M1.F
DE
|
€35.20 40.63 USD |
-1.12
|
€622.29M 718.33M USD | €22.00 25.4 USD | €35.20 40.63 USD | €35.20 40.63 USD | €622.29M 718.33M USD | 26.07 | €1.35 1.56 USD | ||
CorMedix Inc.
19KA.F
DE
|
€7.50 8.66 USD |
+2.52
|
€588.39M 679.2M USD | €500.00 577.17 USD | €7.50 8.66 USD | €7.50 8.66 USD | €588.39M 679.2M USD | 3.96 | €1.89 2.18 USD | ||
Aclaris Therapeutics, Inc.
8AT.F
DE
|
€4.18 4.83 USD |
+7.67
|
€584.07M 674.22M USD | €500.00 577.17 USD | €4.18 4.83 USD | €4.18 4.83 USD | €584.07M 674.22M USD | 0 | -€0.49 -0.5 USD | ||
CytomX Therapeutics, Inc.
6C1.F
DE
|
€2.61 3.01 USD |
-3.77
|
€567.12M 654.64M USD | €1.00K 1.15K USD | €2.61 3.01 USD | €2.61 3.01 USD | €567.12M 654.64M USD | 0 | -€0.45 -0.5 USD | ||
Genfit S.A.
XUP.F
DE
|
€10.64 12.28 USD |
-2.39
|
€533.02M 615.29M USD | €630.00 727.23 USD | €10.64 12.28 USD | €10.64 12.28 USD | €533.02M 615.29M USD | 0 | -€1.72 -1.9 USD | ||
Genfit S.A.
XUP.SG
DE
|
€10.60 12.24 USD |
-0.38
|
€531.02M 612.97M USD | €0.00 0 USD | €10.56 12.19 USD | €10.60 12.24 USD | €531.02M 612.97M USD | 0 | -€1.72 -1.9 USD | ||
Opthea Limited
UKJ2.F
DE
|
€3.00 3.46 USD |
0
|
€512.99M 592.16M USD | €0.00 0 USD | €3.00 3.46 USD | €3.00 3.46 USD | €512.99M 592.16M USD | 0 | -€1.94 -2.2 USD | ||
Altimmune, Inc.
3G0.F
DE
|
€2.51 2.89 USD |
+7.28
|
€487.16M 562.34M USD | €850.00 981.18 USD | €2.51 2.89 USD | €2.51 2.89 USD | €487.16M 562.34M USD | 0 | -€0.80 -0.9 USD | ||
Nxera Pharma Co., Ltd.
JSS.F
DE
|
€5.20 6 USD |
0
|
€477.00M 550.62M USD | €5.00 5.77 USD | €5.20 6 USD | €5.20 6 USD | €477.00M 550.62M USD | 0 | -€0.75 -0.8 USD | ||
Achieve Life Sciences, Inc.
SP4P.F
DE
|
€4.40 5.08 USD |
+4.76
|
€451.70M 521.41M USD | €30.00 34.63 USD | €4.40 5.08 USD | €4.40 5.08 USD | €451.70M 521.41M USD | 0 | -€0.93 -1.07 USD | ||
Prothena Corporation plc
0PT.F
DE
|
€7.68 8.87 USD |
-0.88
|
€402.07M 464.13M USD | €1.50K 1.73K USD | €7.68 8.87 USD | €7.68 8.87 USD | €402.07M 464.13M USD | 0 | -€2.45 -2.8 USD | ||
REGENXBIO Inc.
RB0.F
DE
|
€7.77 8.97 USD |
-1.82
|
€401.69M 463.69M USD | €120.00 138.52 USD | €7.77 8.97 USD | €7.77 8.97 USD | €401.69M 463.69M USD | 0 | -€4.89 -5.6 USD | ||
Shanghai Haohai Biological Technology Co., Ltd.
5HB.F
DE
|
€1.75 2.02 USD |
+2.34
|
€393.72M 454.49M USD | €900.00 1.04K USD | €1.75 2.02 USD | €1.75 2.02 USD | €393.72M 454.49M USD | 12.50 | €0.14 0.16 USD | ||
Valneva SE
AYJ0.F
DE
|
€4.10 4.73 USD |
-8.07
|
€388.78M 448.78M USD | €6.12K 7.06K USD | €4.10 4.73 USD | €4.10 4.73 USD | €388.78M 448.78M USD | 0 | -€1.60 -1.8 USD | ||
Avacta Group Plc
RTQ1.F
DE
|
€0.82 0.94 USD |
-7.39
|
€381.87M 440.8M USD | €3.67K 4.24K USD | €0.82 0.94 USD | €0.82 0.94 USD | €381.87M 440.8M USD | 0 | -€0.10 -0.1 USD | ||
Ocumension Therapeutics
5DG.F
DE
|
€0.47 0.55 USD |
-2.87
|
€381.06M 439.87M USD | €42.00 48.48 USD | €0.47 0.55 USD | €0.47 0.55 USD | €381.06M 439.87M USD | 0 | -€0.03 -0.03 USD | ||
Editas Medicine, Inc.
8EM.F
DE
|
€2.37 2.74 USD |
+3.04
|
€363.70M 419.84M USD | €150.00 173.15 USD | €2.37 2.74 USD | €2.37 2.74 USD | €363.70M 419.84M USD | 0 | -€0.99 -1.1 USD | ||
Ovid Therapeutics Inc.
1OT.F
DE
|
€1.92 2.22 USD |
-1.03
|
€358.35M 413.65M USD | €1.10K 1.27K USD | €1.92 2.22 USD | €1.92 2.22 USD | €358.35M 413.65M USD | 0 | -€0.18 -0.2 USD | ||
Laekna, Inc.
4U4.F
DE
|
€0.78 0.9 USD |
-1.27
|
€350.48M 404.57M USD | €3.00 3.46 USD | €0.78 0.9 USD | €0.78 0.9 USD | €350.48M 404.57M USD | 0 | -€0.08 -0.09 USD | ||
Formycon AG
FYB.F
DE
|
€19.42 22.42 USD |
0
|
€343.21M 396.18M USD | €850.00 981.18 USD | €19.42 22.42 USD | €19.42 22.42 USD | €343.21M 396.18M USD | 0 | -€3.66 -4.2 USD | ||
|
좋아하는 주식 없음
아직 즐겨찾는 주식이 없습니다. 여기에서 보려면 즐겨찾기에 추가하세요. |
|||||||||||


